Exclusive Offer for Those Trying It for the First Time! Get 1 Month of Unlimited Access for Only $24.50 (Regular Price $49) and Save $24.50. Don’t Miss Out – Use Your Discount Code Today!
XS4VURME
Click Here
Contract Details
Title |
In vitro elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab” casa editrice John Wiley and sons Inc. 111 River street Hoboken NJ 07030 USA |
|||
---|---|---|---|---|
You can sign up and unlock it for freeAccess to Public and Private Sector Business Opportunities for 200+ Countries |
||||
Country | ||||
Language | Italian | |||
Organization | ||||
Published Date | 29.11.2024 | |||
Awarded Date | 26.11.2019 | |||
Overview | CIG ZCF2982ED6 Struttura proponente FARMACOLOGIA TRASLAZIONALE - IFT - Sede Roma Tor Vergata Codice Fiscale: 80054330586 Oggetto del bando In vitro elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab” casa editrice John Wiley and sons Inc. 111 River street Hoboken NJ 07030 USA Procedura di scelta del contraente AFFIDAMENTO IN ECONOMIA - AFFIDAMENTO DIRETTO Elenco degli operatori invitati a presentare offerte JOHN WILEY AND SONS 111 RIVER STREET HOBOKEN NJ 07030 Identificativo Fiscale Estero: 13-559-3032Aggiudicatario John Wiley & Sons, Inc. Identificativo Fiscale Estero: 13-559-3032 Importo di aggiudicazione 600,00 Tempi di completamento dell'opera, servizio o fornitura Inizio: 27/11/2019 Fine: 31/12/2020 Importo delle somme liquidate ad oggi 538,86 Visualizza su BDNCPhttps://dati.anticorruzione.it/superset/dashboard/dettaglio_cig/?cig=ZCF2982ED6 | |||
NAICS |
-
|
|||
CPVS |
-
|
|||
UNSPSC |
-
|
|||
Regions | ||||
Sectors | ||||
Contractor | ||||
Contract Value |
538,86 EUR
|
URL | ||
Share |
Title |
---|
In vitro elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab” casa editrice John Wiley and sons Inc. 111 River street Hoboken NJ 07030 USA |
Country |
Language |
Italian |
Organization |
Published Date |
29.11.2024 |
Awarded Date |
26.11.2019 |
Overview |
CIG ZCF2982ED6 Struttura proponente FARMACOLOGIA TRASLAZIONALE - IFT - Sede Roma Tor Vergata Codice Fiscale: 80054330586 Oggetto del bando In vitro elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab” casa editrice John Wiley and sons Inc. 111 River street Hoboken NJ 07030 USA Procedura di scelta del contraente AFFIDAMENTO IN ECONOMIA - AFFIDAMENTO DIRETTO Elenco degli operatori invitati a presentare offerte JOHN WILEY AND SONS 111 RIVER STREET HOBOKEN NJ 07030 Identificativo Fiscale Estero: 13-559-3032Aggiudicatario John Wiley & Sons, Inc. Identificativo Fiscale Estero: 13-559-3032 Importo di aggiudicazione 600,00 Tempi di completamento dell'opera, servizio o fornitura Inizio: 27/11/2019 Fine: 31/12/2020 Importo delle somme liquidate ad oggi 538,86 Visualizza su BDNCPhttps://dati.anticorruzione.it/superset/dashboard/dettaglio_cig/?cig=ZCF2982ED6 |
NAICS |
- |
CPVS |
- |
UNSPSC |
- |
Regions |
Europe Southern Europe Western Europe |
Sectors |
Building Supply Law and Legal Printing and Publishing Construction Energy-Power and Electrical Computer Hardwares and Consumables Aviation Building Material Marine |
Contractor |
Contract Value |
538,86 EUR
|
URL |
|
Share |
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
To Follow
Project News
Add Project News Alert
To Follow
Trade B2b
Add Trade B2b Alert
Similar Contracts